RxDoctor Payments DataLook up a doctor →

Juan Suarez, MD

Adult Reconstructive Orthopaedic Surgery · Miami, FLNPI 1548291412

Payments from drug & device makers

$3,904,446in general payments, 2019–2025

Across 324 payments — averaging $12,051 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Depuy Synthes Products, Inc.$3.4M
  • Omnilife Science, Inc$368K
  • Medacta USA, Inc.$88K
  • Corin USA$44K
  • Zimmer Biomet$15K
  • Medical Device Business Services, Inc.$11K
  • plus $8K from 19 others
$5,359in research payments, 2019–2025

Across 6 payments — averaging $893.11 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Omnilife Science, Inc$5K

What the payments were for

  • Royalty or licence$410,22811%
  • Consulting fees$62,7002%
  • Travel & lodging$34,2661%
  • Food & beverage$11,2520%
  • Other$3,370,75087%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,904,446 in reported general payments places this provider in the 95th percentile of 96 adult reconstructive orthopaedic surgery providers in Florida.

See all adult reconstructive orthopaedic surgery providers in Florida

Medicare billing

Part B allowed, 2024
$280,464
Medicare patients
279
Services billed
1,087

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mupirocin404$3,000
Celecoxib43$561
Amoxicillin63$126
Oxycodone Hcl15$126
Methylprednisolone13$123
Meloxicam57$89
Tramadol Hcl17$62
Ibuprofen13$54
Prednisone36$40
Clindamycin Hcl17$37

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →